Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)R&D In ProcessReceivables - NetReceivables - OtherShares Repurchased
Ratios

Neurocrine Biosciences (NBIX) Shares Repurchased (2024 - 2025)

Neurocrine Biosciences (NBIX) has disclosed Shares Repurchased for 2 consecutive years, with $17.7 million as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Shares Repurchased changed N/A year-over-year to $17.7 million, compared with a TTM value of $167.7 million through Dec 2025, down 44.1%, and an annual FY2025 reading of $167.7 million, down 44.1% over the prior year.
  • Shares Repurchased was $17.7 million for Q2 2025 at Neurocrine Biosciences, down from $150.0 million in the prior quarter.
  • Across five years, Shares Repurchased topped out at $300.0 million in Q4 2024 and bottomed at $17.7 million in Q2 2025.